DSpace JSPUI


DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More

Please use this identifier to cite or link to this item: http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/8128
Title: The state of costing research for HIV interventions in sub-Saharan Africa
Keywords: Africa South of the Sahara Cost-Benefit Analysis Global Health , economics HIV Infections , diagnosis HIV Infections , economics, HIV Infections , prevention control HIV Infections , therapy Health Care Costs , statistics numerical data, Health Services , economics Humans Tuberculosis , diagnosis Tuberculosis , economics Tuberculosis , prevention control Tuberculosis , therapy
Issue Date: 2020
Publisher: ESPM INSP
Abstract: Abstract The past decade has seen a growing emphasis on the production of high-quality costing data to improve the efficiency and cost-effectiveness of global health interventions. The need for such data is especially important for decision making and priority setting across HIV services from prevention and testing to treatment and care. To help address this critical need, the Global Health Cost Consortium was created in 2016, in part to conduct a systematic search and screening of the costing literature for HIV and TB interventions in low- and middle-income countries (LMIC). The purpose of this portion of the remit was to compile, standardise, and make publicly available published cost data (peer-reviewed and gray) for public use. We limit our analysis to a review of the quantity and characteristics of published cost data from HIV interventions in sub-Saharan Africa. First, we document the production of cost data over 25 years, including density over time, geography, publication venue, authorship and type of intervention. Second, we explore key methods and reporting for characteristics including urbanicity, platform type, ownership and scale. Although the volume of HIV costing data has increased substantially on the continent, cost reporting is lacking across several dimensions. We find a dearth of cost estimates from HIV interventions in west Africa, as well as inconsistent reporting of key dimensions of cost including platform type, ownership and urbanicity. Further, we find clear evidence of a need for renewed focus on the consistent reporting of scale by authors of costing and cost-effectiveness analyses.
URI: sicabi.insp.mx:2020-None
https://www.tandfonline.com/doi/epdf/10.2989/16085906.2019.1679200?needAccess=true&role=button
https://www.doi.org/10.2989/16085906.2019.1679200
http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/8128
Appears in Collections:Artículos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.